LAB - ABBOTT ALINITY-M PCR MOLECULAR REAGENTS & SUPPLIES Notice of Intent to Sole source

Background
The New York Harbor Healthcare System, specifically the Manhattan Campuses, is issuing a Notice of Intent to award a sole source contract to Abbott Molecular, Inc. This contract aims to procure proprietary reagent kits and consumables for the Laboratory Department. The agency has determined through market research that Abbott Molecular, Inc. is the only vendor capable of providing these specific items that are compatible with VA-owned machines.

Work Details
The contract includes the following proprietary reagent kits and consumables:

- ALNTY M HCV AMP KIT US
- ALNTY M HCV CTL KIT US
- ALNTY M HCV CAL KIT US
- ALNTY M HIV-1 AMP KIT US
- ALNTY M HIV-1 CTL KIT US
- ALNTY M HIV-1 CAL KIT US
- ALNTY M HBV AMP KIT
- ALNTY M HBV CTRL KIT
- ALNTY M HBV CAL KIT
- ALNTY M SARS-CoV-2 AMP KIT
- ALNTY M SARS-CoV-2 CTRL KIT
- ALNTY M SAMPLE PREP KIT 2
- ALNTY M SAMPLE PREP KIT 1
- ALNTY M LYSIS SOLUTION
- ALNTY M ETHANOL SOLUTION
- ALNTY M DILUENT SOLUTION
- ALNTY M VAPOR BARRIER S.

Period of Performance
The period of performance for this contract is from October 1, 2026 through September 30, 2031.

Place of Performance
The products will be delivered to the New York Harbor Healthcare System Manhattan Campuses located at 423 East 23rd Street, NY, NY 10010.